Login / Signup

An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.

Christopher RaspinRichard LaugharneFrancesca BarionVicki PollitJoanna MurphyLaura SawyerVanessa Danielson
Published in: Journal of medical economics (2021)
VNS is expected to be a cost-effective intervention in the treatment of DRE in the English National Health Service.
Keyphrases
  • drug resistant
  • randomized controlled trial
  • multidrug resistant
  • pseudomonas aeruginosa